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Definitive hematopoiesis emerges during embryo-
genesis via an endothelial-to-hematopoietic transi-
tion. We attempted to induce this process in mouse
fibroblasts by screening a panel of factors for hemo-
genic activity. We identified a combination of four
transcription factors, Gata2, Gfi1b, cFos, and Etv6,
that efficiently induces endothelial-like precursor
cells, with the subsequent appearance of hemato-
poietic cells. The precursor cells express a human
CD34 reporter, Sca1, and Prominin1 within a global
endothelial transcription program. Emergent he-
matopoietic cells possess nascent hematopoietic
stem cell gene-expression profiles and cell-surface
phenotypes. After transgene silencing and reaggre-
gation culture, the specified cells generate hemato-
poietic colonies in vitro. Thus, we show that a simple
combination of transcription factors is sufficient
to induce a complex, dynamic, and multistep devel-
opmental program in vitro. These findings provide
insights into the specification of definitive hemo-
genesis and a platform for future development of pa-
tient-specific stem and progenitor cells, as well as
more-differentiated blood products.
INTRODUCTION
Hematopoiesis originates from multipotent hematopoietic
stem cells (HSCs). These arise during development and seq-
uentially colonize fetal liver, spleen, and finally bone marrow
(BM), where they function throughout adult life. Definitive murine
HSCs are first detected at embryonic day 10.5 (E10.5) in clusters
associated with the ventral floor of the dorsal aorta in the aorta-
gonad-mesonephros (AGM) region and after E11.5 in the fetal
liver, yolk sac, and placenta (reviewed by Medvinsky et al.,
2011). It is thought that HSCs emerge from a small population
of ‘‘hemogenic’’ endothelial cells (Bertrand et al., 2010; BoissetCet al., 2010; Zovein et al., 2008). Studies have suggested a
transition wherein individual hematopoietic cells ‘‘bud’’ directly
from endothelial cells (Bertrand et al., 2010; Boisset et al.,
2010; Eilken et al., 2009; Kissa and Herbomel, 2010; Lancrin
et al., 2009).
Several transcription factors (TFs) have been implicated in
endothelial-to-hematopoietic transition and HSC specification,
including Runx1 (North et al., 1999), Scl (Porcher et al., 1996),
Gata2 (Tsai et al., 1994), Gfi1/Gfi1b (Lancrin et al., 2012), and
Notch1 (Kumano et al., 2003). Mutant Scl–/– orRunx1–/– embryos
have no AGM clusters or hematopoietic stem and progenitor
cells (HSPCs) (North et al., 1999; Porcher et al., 1996). Specific
deletion of Runx1 in the endothelium and in emergent HSCs in-
hibits cluster formation and hematopoietic specification (Li
et al., 2006). Recently, it has been suggested that Sca1, encoded
by the Ly6a gene, marks hemogenic endothelial cells. Indeed,
Ly6a-driven expression of Cbfb, a Runx1 cofactor, rescues pro-
duction of HSCs (Chen et al., 2011). Mutant Notch1–/– embryos
lack definitive hematopoiesis although they develop normal
numbers of yolk-sac progenitors (Kumano et al., 2003). Several
TFs have been implicated in HSC self-renewal. Specifically, de-
letions of Etv6 (Hock et al., 2004b), PU.1 (Burda et al., 2010), Gfi1
(Hock et al., 2004a), or Gata2 (Rodrigues et al., 2005) result in
adult HSC defects, whereas loss of Sox17 causes defects in
fetal-liver HSCs (Kim et al., 2007). Gain-of-function studies
have identified factors such as HoxB4, HoxA9, PU.1, Erdr1,
and cFos that expand HSC activity (Deneault et al., 2009).
Despite the accumulating molecular data, in vitro efforts to pro-
duce transplantable HSCs from embryonic stem cells (ESCs)
have been largely unsuccessful. Dissecting the hemogenic pro-
cess may provide key insights for the in vitro generation of defin-
itive HSCs.
Studies by Yamanaka and colleagues demonstrated that
Oct4, Sox2, Klf4, and cMyc can reprogram fibroblasts into
induced pluripotent stem cells (iPSCs) (Takahashi and Yama-
naka, 2006). Defined TFs can also interconvert differentiated
cell types (reviewed by Pereira et al., 2012). Recently, Sox2 alone
or in combination with other TFs has been used to convert fibro-
blasts into neural stem cells (Lujan et al., 2012; Ring et al., 2012).
Collectively, these studies led us to ask whether a minimal num-
ber of TFs can specify definitive hematopoiesis and HSCs.ell Stem Cell 13, 205–218, August 1, 2013 ª2013 Elsevier Inc. 205
Figure 1. Screening for Hematopoietic
Fate-Inducing Factors
(A) Strategy for testing hematopoiesis-inducing
factors. Mouse MEFs were isolated from 34/
H2BGFP double-transgenic mice and transduced
with pools of candidate TFs (pMXs-TFs). Four
days after transduction, MEFs were replated onto
AFT024 stroma with or without cytokines (SCF,
Flt3l, IL-3, and IL-6), cocultured for 14–19 days,
and screened for GFP via immunofluorescence
and flow cytometry.
(B) MEFs transduced with pMXs-mCherry or the
18-TF cocktail plus mCherry were analyzed at day
21. The emergence of colonies was observed only
in the 18-TF pool +mCherry (upper panels) and not
in the mCherry control (lower panels). mCherry
(red) shows the MEF origin of colonies and bright
field shows morphologies.
(C) A single colony was assayed for 34/H2BGFP
activation (green) 21 and 23 days after trans-
duction with 18 TFs. Dashed lines highlight
morphological changes. Scale bars represent
100 mm.
(D) MEFs were transduced with 18 TFs or empty
vector control (C) and transferred to AFT024,
methylcellulose-containing media (MC), gelatin,
or Matrigel-coated dishes with cytokines. GFP+
and GFP colonies were counted via immuno-
fluoresence and bright-field microscopy at
21 days.
(E) MEFs were transduced with retroviral pools
expressing 18 TFs, 14 TFs, or empty vector control
(C) and cultured with (+) and without () cytokines
(Cyto) on AFT024 stroma.
(F) 34/H2BGFP MEFs were transduced with
PU.1 + CEBPa. FACS plots show the expression
of CD45, Mac1, and no activation of 34/H2BGFP
at day 8.
(G) GFP+ and GFP colonies after removal of in-
dividual factors from the 14-TF pool. Factors
whose removal decreased colony numbers were
selected (asterisks). Colony numbers are per
10,000 infected MEFs (mean ± SEM).
See also Figure S1.
Cell Stem Cell
Induction of HemogenesisWe show that the four TFs, Gata2, Gfi1b, cFos, and Etv6,
convert fibroblasts into endothelial-like cells that subsequently
generate HSPC-like cells. These cells adopt emergent HSC-
like gene-expression profiles and cell-surface phenotypes. This
is the first demonstration that a complex developmental process
can be ‘‘set in motion’’ in vitro by a defined combination of TFs.
RESULTS
A Screen for Hematopoiesis-Inducing Transcription
Factors
Two approaches were used to identify candidate TFs: (1) litera-
ture mining and (2) global profiling for defining genes with high
expression levels in HSCs relative to mature blood cells and
other tissues. Profiling studies utilized BM HSCs isolated from
a double-transgenic mouse, huCD34tTA3 TetO-H2BGFP (here-
after called 34/H2BGFP). H2BGFP is specifically expressed in
immature HSPC compartments, and cells with long-term-repo-206 Cell Stem Cell 13, 205–218, August 1, 2013 ª2013 Elsevier Inc.pulating (LT)-HSC cell-surface phenotypes have the highest
GFP levels (Schaniel and Moore, 2009). Synthesis of H2BGFP
is turned off by doxycycline (Dox) administration, and the label
is progressively diluted via cell division. Dormant, nondividing
HSCs retain high levels of GFP and have very robust in vivo repo-
pulation activity, whereas active dividing cells lose activity (J.Q.
and K.M., unpublished data). HSCs with progressively
decreasing levels of GFP were profiled for identification of the
TFs present in the brightest population. Using this method
together with data mining, a total of 18 TFs were identified (Fig-
ures S1A and S1B and Table S1 available online).
All 18 TFs were individually inserted into the pMXs retroviral
vector. Target mouse embryonic fibroblasts (MEFs) were
obtained from 34/H2BGFP embryos. The reporter should be
reactivated when a hematopoietic or endothelial progenitor
fate is acquired (Radomska et al., 2002) (Figure 1A). To eliminate
contamination with hematopoietic and very rare GFP+ cells, we
removed residual CD45+ and GFP+ cells via cell sorting prior to
Figure 2. Combination of Gata2, Gfi1b,
cFos, and Etv6 Induces Efficient Activation
of 34/H2BGFP
(A and B) GFP+ colony numbers were counted
after removal of individual TFs from the pool
of seven TFs (Gfi1b/cFos/Gata2/Etv6/Scl/Bmi1/
Runx1) (A), five TFs (Gfi1b/cFos/Gata2/Etv6/Scl),
and three TFs (Gfi1b/cFos/Gata2) (B). Fluores-
cent colonies were counted 22 days after
transduction with (+) or without () cytokines.
TFs whose removal decreased the colony
number were selected (asterisks). Four TFs
(Gfi1b/cFos/Gata2/Etv6) yielded the optimal effi-
ciency of activation (4%–7%). Colony numbers
per 10,000 infected MEFs are shown (mean ±
SEM).
(C) MEFs were analyzed via flow cytometry
22 days after transduction with pools of
seven, five, four, three (Gfi1b/cFos/Gata2), or
two TFs (3F – the indicated TF). The percent-
ages of GFP+ cells are shown. Auto, auto-
fluorescence.
See also Figure S2.
Cell Stem Cell
Induction of Hemogenesistransduction. MEFswere transducedwith the 18-TF cocktail and
plated 4 days later on AFT024 HSC-supporting stromal cells
(Moore et al., 1997). After 21 days, we observed the emergence
of colonies organized into circular structures (Figure 1B and Fig-
ure S1C). These structures continued over time, and rare col-
onies expressed nuclear GFP, reflecting 34/H2BGFP activation
(Figures 1C and S1D). Colonies or GFP+ cells were never
observed with control vectors. We next investigated the reprog-
ramming conditions using a variety of substrates, including
AFT024, methylcellulose, gelatin, and Matrigel. AFT024 cocul-
tures yielded the highest colony numbers and were the only con-
dition supporting reporter activation (Figure 1D). To identify the
critical TFs, we sequentially removed factors from the starting
cocktail. Because of their broader expression in dormant and
active HSCs as well as in other tissues, Trib3, Bex2, Tcf3, and
Hhexwere initially removed, yielding a cocktail of 14 TFs (Figures
S1A and S1B). MEFs transduced with the 14 TFs were cocul-
tured with AFT024 with or without cytokines. GFP+ and GFP
colonies were quantified after 18 days. We observed increases
in total and GFP+ colony numbers, and the latter appeared
without cytokines (Figure 1E). As an additional control for 34/
H2BGFP reporter specificity, CEBPa and PU.1 were used to
convert MEFs into macrophage-like cells (Feng et al., 2008),
and as expected, no reporter activation was observed
(Figure 1F).Cell Stem Cell 13, 205–21Gata2, Gfi1b, cFos, and Etv6 Are
Sufficient for Efficient 34/H2BGFP
Activation
We next deleted individual TFs from
the pool of 14 (Figure 1G). Removal of
PU.1, Etv3, HoxA9, or Erdr1 yielded
increased total and GFP+ colony
numbers. Deletion of Lyl1, Scl, Mllt3,
and Meis1 did not significantly alter
colony numbers. Removal of Gata2,
Gfi1b, or cFos reduced colony numbersand abolished GFP+ colonies, showing that these are
essential. Removal of Bmi1 decreased GFP colony numbers.
We selected seven TFs (Gata2, Gfi1b, cFos, Etv6, Scl, Bmi1,
and Runx1) for subsequent studies. Scl and Lyl1 are largely
redundant (Souroullas et al., 2009), and this is probably
also the case for Etv6, Etv3, and PU.1. We retained Runx1
because of its requirement in the endothelial-to-hematopoietic
transition (Li et al., 2006). Transduction with seven TFs
produced a 14-fold increase in GFP+ colonies relative to
the pool of 14 (3.5 to 50) (Figure 2A). Addition of cytokines
resulted in a 1.5- to 3-fold increase in total colony numbers
and in larger GFP+ colonies (Figures 2A and S3A). Two
additional rounds of factor removal showed that four TFs
(Gata2, Gfi1b, cFos, and Etv6) were sufficient for 34/H2BGFP
activation (Figure 2B). Activation efficiency after 22 days was
also dramatically increased (4%–7%) (Figures 2B and 2C).
Removal of Etv6 slightly reduced the percentage of GFP+ cells
(4.3% to 2.8%), whereas exclusion of each of the remaining
three (Gata2, Gfi1b, and cFos) had a dramatic negative impact
on GFP+ cells. We next analyzed the in vivo expression
patterns of the four TFs. Gata2, Gfi1b, and Etv6 messenger
RNAs (mRNAs) are enriched in both phenotypically defined
and dormant HSCs (Figure S2). Vector integration was also
confirmed in GFP+ cells generated with 11 and 4 TFs
(Figure S2D).8, August 1, 2013 ª2013 Elsevier Inc. 207
Figure 3. Induced 34/H2BGFP+ Cells Express Endothelial and Hematopoietic Markers Similarly to HSCs
(A) 34/H2BGFP MEFs were transduced with pools of seven, five, four, or three TFs (as indicated by dots in the upper panel) and cocultured with AFT024 stroma
with (+) or without () cytokines. At day 0 (MEFs), day 4, day 20, and day 40 after transduction, groups of 100 GFP+ cells were sorted and assayed for expression.
MEFs transduced with pMXs-mCherry were included as controls. Levels of mRNA expression were compared to purified HSC populations isolated from the BM
of 34/H2BGFP mice (from left to right: LSKCD48, LSKCD48Flk2+, LSKCD48Flk2CD34+, LSKCD48Flk2CD34, LSKCD48Flk2CD34CD150+). Red
(legend continued on next page)
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Cell Stem Cell
Induction of HemogenesisCells with Activated 34/H2BGFP Express Endothelial
and Hematopoietic Genes
To characterize gene expression in GFP+ cells, we used the Flu-
idigm BioMark system. Reporter MEFs were transduced with
pools of seven, five, four, or three TFs and cultured with
AFT024 for 20 and 40 dayswith andwithout cytokines (Figure 3A,
upper panel). Nontransduced andmCherry-transducedMEFs as
well as GFP+ cells from TF-transduced samples were sorted into
96-well plates (100 cells per sample per well in duplicate or trip-
licate). Gene-expression patterns were compared to BM HSPC
populations isolated from adult 34/H2BGFP mice. Dramatic
gene-expression changes in transduced cells (relative to
MEFs) were observed at days 20 and 40. GFP+ cells show
time-dependent transcriptional changes, highlighting the dy-
namic nature of the induction process. Remarkably, unsuper-
vised hierarchical clustering placed day 40 GFP+ cells generated
without cytokines closest to bona fide adult HSCs (Figure 3A).
We observed decreased expression of fibroblast-specific genes
such as Vim, Acta2, Fn1, and Fbn2 between days 0 and 20 (Fig-
ures 3A and 3B). At day 20 we detected high levels of Prom1
(Prominin1) and Ly6a, as well as activation of KitL, Csf1r,
Cd34, and Il3ra (Figure 3B). Expression profiles do not showma-
jor differences in GFP+ cells generated with different TF pools (as
long as Gata2, Gfi1b, and cFos are present). Thus, the additional
factors affect the efficiency, but not the global reprogramming of
gene expression. At day 40 we detected coexpression of he-
matopoietic (Csf3r, Il3ra, Cd43, Kit, Mpl, Cd45, and Cd41) and
endothelial and/or endothelial progenitor markers (Vwf, Nos3,
and Id1). Interestingly, at day 40 we detected markers of emer-
gent and fetal HSCs (Cd93/AA4.1, Cd41, and Sox17) and hemo-
genic endothelium (Etv2 and Runx1) (Figure 3B). Using specific
primers we also demonstrated expression of endogenous
Gata2 (Figure 3B).
Sequential Induction of Precursor and Hemogenic
Colonies with Gata2, Gfi1b, cFos, and Etv6
To further characterize emerging cells, we examined the expres-
sion of Sca1 and Prom1. After 22 days, 50%–60% of the GFP+
cells were Sca1+ (data not shown), and 36% were Prom1+ (Fig-
ure 4A). Prom1+ cells also expressed high levels of Sca1 (89%),
confirming our mRNA analyses in day 20 GFP+ cells (Figure 3B).
The four-TF cocktail (Gata2, Gfi1b, cFos, and Etv6) induced
higher percentages of GFP+Prom1+ cells in comparison to seven
and five factors and other combinations of four factors
(Figure 4B).
At 35 days, we observed emergence of colonies containing
clusters of nonadherent GFP+ cells (Figure 4C). Remarkably,
we identified clusters that express the endothelial markers
Tie2, CD31, VE-Cadherin, and the panhematopoietic marker
CD45 (Figure 4C). We next sought to determine optimal condi-
tions for generating hematopoietic cell clusters. With four TFs,
AFT024 was no longer necessary for generating day 20 GFP+indicates increased expression and green indicates decreased expression over
HSCs. Data were normalized to Hprt expression, analyzed by Cluster 3.0, and d
(B) Relative mRNA expression levels of fibroblast-associated genes (Acta2; high
Kitl, Csf1r, Cd34, and Il3ra; highlighted in blue). Expression of hematopoietic (C
emerging HSC markers (Sox17 and Cd93/AA4.1) (red). Expression of Runx1, B
endogenous Gata2 (endo; brown). Transductions from seven to three TFs are or
Cor day 35 nonadherent hematopoietic cell clusters (Figures
S3A, S3B, and S3C). In addition, inclusion of cytokines
decreased the numbers of nonadherent cells. Cultures on gelatin
without cytokines yielded 9%CD45+ cells at day 35 (Figure S3D).
We tested the effects of individual cytokines and found that inter-
leukin-6 (IL-6) is inhibitory (2% CD45+), whereas IL-3 has a pos-
itive effect (27% CD45+) (Figures S3D and S3E). The latter may
be due to the expansion of CD45+ cells or maturation from pre-
cursor endothelial-like cells as previously reported in mouse
AGM (Taoudi et al., 2008). Kinetic analyses of endothelial and he-
matopoietic markers showed that Tie2 expression is transient
whereas CD45 expression increases steadily over time (Fig-
ure 4D). This is consistent with the role of Gfi1b in loss of endo-
thelial identity (Lancrin et al., 2012).
Between days 30 and 40, we identified several cellular compo-
nents in GFP+ cultures (Figure 4E) associated with emergence of
CD45+ cells: (1) small nonadherent or semiadherent GFP+CD45+
cells with compact nuclei, (2) large adherent GFP+CD45 cells
often found in the margins of circular structures, and (3) very
large adherent GFP+CD45 cells that contain one ormore nuclei.
CD45+ cells are often seen in association with GFP+CD45 cells,
particularly when semiadherent (Figure 4E, right panel). We
monitored emergence of CD45+ cells by using time-lapse imag-
ing for morphology,reporter activation, and live staining for CD45
(Movie S1). We found that small GFP+CD45 cells are associ-
ated with large adherent cells. Acquisition of CD45 is often
accompanied by dissociation of nonadherent cells from large
cells that then die (Movie S2).
In order to determine whether we could isolate the precursor
for the emergent hematopoietic cells, we sorted the GFP+Sca1+
Prom1+ population and cultured it on gelatin (Figure 4F, left
panels). After 6 days, we observed a higher percentage of
CD45+ cells in cultures initiated with the sorted cells (53%)
than in those initiated with the unsorted population (9%) (Fig-
ure 4F, right panel). CD45+GFP+ cells emerge in association
with large, flat CD45GFP+ cells (Figure 4F, middle panels),
which are also Mac1 negative (data not shown). These data sug-
gest that GFP+Sca1+Prom1+ cells are hemogenic precursors.
Precursor GFP+ Cells Display an Endothelial-like Gene-
Expression Signature
To better define the precursor and emergent hematopoietic
cells, we performed mRNA sequencing (mRNA-seq) on popula-
tions generated after transduction with Gata2, Gfi1b, cFos, and
Etv6. Two biological replicates were sorted from nontransduced
MEFs, day 20 GFP+Sca1+Prom1+ cells, and the cKit+ and cKit
subsets within the day 35 GFP+CD45+ population (Figure S4A).
Replicates correlate with each other, in contrast to comparisons
between different samples (Figures S4B and S4C). We used
nonnegative matrix factorization coupled with consensus clus-
tering to analyze sample diversity and showed that MEFs are fol-
lowed by day 20 cells and day 35 cKit+ and cKit cells (Figure 5B,the mean. Shading highlights the similarity between day 40 samples and BM
isplayed by TreeView.
lighted in black) and markers with expression initiated at day 20 (Prom1, Ly6a,
sf3r, Cd43, Kit, Mpl, Cd45, and Cd41), endothelial (Vwf, Id1, and Nos3), and
mi1, Scl, Etv6, Gfi1b, and cFos total mRNAs (transgene + endogenous) and
dered from left to right. Expression levels are relative to Hprt.
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Figure 4. Induced Hemogenic Colonies
Emerging from a Precursor Cell Type
(A) MEFs were transduced with four TFs (Gata2,
Gfi1b, cFos, and Etv6) and cultured on AFT024
stroma with cytokines. At day 20, GFP+ cells were
analyzed for expression of Prom1 and Sca1.
(B) Quantification of the Prom1+GFP+ cell per-
centage after transduction with seven, five, or four
TFs. The highest percentage was achieved by
transduction with Gfi1b, cFos, Gata2, and Etv6
(3F + Etv6, mean ± SEM).
(C)MEFswere transducedwithsevenTFs, cultured
onAFT024stromawithout cytokines, andanalyzed
at day 35 via immunofluorescence. The emergence
of nonadherent cells is shown. The insert shows a
higher magnification to highlight round, non-
adherent cells. Shown in red is live staining for Tie2,
CD31, VE-cadherin, Sca1, and CD45 as indicated,
and GFP expression is shown in green.
(D) MEFs were transduced with four TFs, cultured
on gelatin, and analyzed sequentially at days 25,
35, and 45. The percentages of CD45+ and Tie2+
cells are shown in gated GFP+ and GFP pop-
ulations. A representative experiment of three is
shown.
(E) MEFs were transduced with four TFs, plated
on gelatin without cytokines, and analyzed at
40 days with immunofluorescence. GFP (green),
CD45 staining (red), and bright field show the
morphology. The following cellular components
are highlighted with arrows: (a) small nonadherent
or semiadherent GFP+CD45+ cells, (b) larger
adherent GFP+CD45 cells, and (c) very large
adherent GFP+CD45 cells.
(F) GFP+Sca1+Prom1+ cells were isolated at day
20 after transduction with four TFs and replated on
gelatin (left). After 6 days, cultured cells were
analyzed via immunofluorescence and flow cy-
tometry (right panels). CD45+ (red) and GFP+
(green) cells emerge in the cultures. Cell bound-
aries (dashed line) and nuclei (arrowhead) of
bigger CD45 cells are highlighted. The insert
shows a higher magnification to highlight GFP+
CD45+ cells. Scale bars represent 100 mm. Flow
plots (far-right panels) show the enrichment of
CD45+ emerging in cultures of sorted versus un-
sorted populations. See also Figure S3.
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Induction of Hemogenesisupper panel). This is consistent with morphological changes
(Figure 5A) and the Fluidigm data (Figure 3). Metagene analysis
showed sets of genes expressed in MEFs and silenced in all
other samples (Figure 5B, lower panel), genes expressed
transiently at day 20, and genes that are expressed in CD45+
cKit+ cells and either silenced or also expressed in CD45+cKit
cells. Metagenes identified in CD45+cKit+ and CD45+cKit cells
show higher overlap than those inMEFs and at day 20 (Figure 5B,
lower panel). Principal component analysis (PCA) placed
MEFs and day 20 and day 35 CD45+ cells very distant from
each other, demonstrating the striking phenotypic transition
from MEFs to day 20 precursors and subsequently to CD45+210 Cell Stem Cell 13, 205–218, August 1, 2013 ª2013 Elsevier Inc.cells. CD45+cKit+ and CD45+cKit are
closely related but clearly distinguishable
by PCA (Figure 5C).Alignment of reads at individual gene loci and quantification by
fragments per kilobase of exon per million fragments mapped
(FPKM) values confirm silencing of MEF genes Acta2, Fbn1,
Fbn2, Fn1, and Col5a2 (Figures 5D and 5E). Ly6a was upregu-
lated 6-fold at day 20, whereas Ly6e was upregulated 2.8-fold
in CD45+cKit+ cells. Both Ly6a and Ly6e genes encode the
Sca1 antigen. CD45 was only detected in day 35 CD45+ cells
(Figure 5D). At day 20, proposed markers of AGM HSC pre-
cursors including podocalyxin-like protein 1 (Pclp-1) (Hara
et al., 1999) and the angiotensin-converting enzyme (Ace) (Sinka
et al., 2012) were detected. Pclp-1, Podxl2, and Ace are up-
regulated 120-, 5-, and 9-fold, respectively (Figure 5E).
Cell Stem Cell
Induction of HemogenesisProangiogenic factors such asHand2,Kdr, Tgfb2, Itga6,Notch4,
KitL, and Proliferin 2/3 (Plf-2/3) were also detected at day 20
(Figure 5E). Indeed, pathway analysis using the PANTHER clas-
sification system showed enrichment of pathways related to
endothelial biology. These include angiogenesis (p value =
2.5 3 1004), Vegf (p value = 5.0 3 1004), Tgfb (p value =
1.0 3 1003), and Integrin signaling (p value = 1.8 3 1004) (Fig-
ure S5B), as well as heterotrimeric G protein signaling, endothe-
lin signaling, and cytokine-mediated inflammation, a process
that may be involved in hemogenesis (Figure S5). Gene ontology
(GO) analysis showed that the extracellular region or matrix, the
actin cytoskeleton, and cell junctions were enriched cellular
component categories. Top molecular function and biological
process GO categories were protein and receptor binding, re-
ceptor activity, cell communication, and signal transduction (Fig-
ure S5). Together, these analyses demonstrate that in GFP+
Sca1+Prom1+ precursors, an endothelial-like gene-expression
program precedes the activation of a hematopoietic program
in emerging CD45+ cells. Some genes, such as Itga6 (encoding
CD49f), are expressed in precursor cells, and their expression
is maintained in emergent hematopoietic cells. Analysis of
CD49f protein confirmed expression in the emergent hematopoi-
etic and endothelial-like cells (Figures 5F and 5G). Analysis of
genes upregulated in day 35 CD45+cKit+ cells using the Mouse
Genome Informatics (MGI) mouse mutant phenotype database
showed that genetic perturbations cause largely hematopoietic
phenotypes (Figure 5H, right panel). In contrast, genes up-
regulated at day 20 impact blood vessel and embryo develop-
ment, as well as other processes (Figure 5H, left panel).
MicroRNA (miRNA) target prediction focused on genes activated
between day 20 and day 35 CD45+cKit+ cells showed highest
enrichment of miR-125 targets (Figure 5I, right panel; p value =
8.48 3 1004). MiR-125 is highly expressed in HSCs and was
shown to expand their numbers in vivo (Guo et al., 2010). Targets
of several other miRNAs implicated in HSPCs (miR-29, miR-142,
miR-19, miR-130, and miR-520) were also identified. In contrast,
at day 20 a different set of miRNA targets were identified,
including those for the vascular-endothelium-specific miR-15
(Figure 5I, left panel; p value = 8.56 3 1003) (Yin et al., 2012)
and others related to endothelial cell biology (miR-99, miR-200,
miR-519 and miR-135).
Emergent Hematopoietic Cells Express Markers of
Definitive Hematopoiesis
We used gene set enrichment analysis (GSEA) to compare the
transition of day 20 precursors to day 35 CD45+cKit+ cells with
published gene sets (Figure 6A). This showed significant enrich-
ment of GSEA database HSC gene sets in the CD45+cKit+ sam-
ples (24 out of 35 HSC gene sets; Fisher’s exact test, p value =
6.6 3 1004; false discovery rate [FDR] < 0.25). Indeed, the
most enriched gene set among the 1,888 in the database was
an HSC gene set (Table S6). Next, we determined whether im-
mune signaling pathways were enriched in the CD45+cKit+ pop-
ulation. Curated immune signaling pathways (32 out of 32) were
enriched in CD45+cKit+ cells including the Kit receptor, IL-3, and
B and T cell receptor, in agreement with hematopoietic specifi-
cation. We next used GSEA to compare CD45+cKit+ to CD45+
cKit cells (Figure 6B). Consistent with PCA (Figure 5C), fewer
gene sets were enriched than in comparison to day 20 cells.CFour HSC gene sets were enriched, including three from LT-
HSCs. More-significant enrichment of LT-HSC gene sets was
found in the CD45+cKit+ sample (3 out of 3 LT-HSCs gene
sets; Fisher’s exact test, p value = 5.1 3 1005, FDR < 0.35).
The enriched signaling pathways include Hedgehog, Wnt, a6b4
Integrin, and OSM, consistent with their roles in hemogenesis.
To address whether the induced hematopoietic cells were
closest to ‘‘specifying’’ versus ‘‘definitive’’ HSCs, we compared
our data to the recently published data sets from BM, fetal-
liver, placenta, AGM, and yolk-sac HSCs (McKinney-Freeman
et al., 2012). Remarkably, the specified CD45+cKit+ and CD45+
cKit cells show a robust clustering, with nascent HSCs pro-
spectively isolated from the AGM, placenta, and early fetal liver
(Figure 6C).
Global analysis also revealed activation of HSC transcriptional
regulators including Scl, Fli1, Hhex, Smad6, Lyl1, Lmo2, Runx1,
Sox17,Msi2, and Gfi1. Master regulators of the lymphoid (Ikzf1),
myeloid (PU.1) and erythroid (Eto2 and Fog1) lineages were also
expressed in CD45+cKit+ and CD45+cKit cells (Figure 6D). We
next analyzed genes in the Notch signaling pathway because
of its role in the onset of definitive, but not primitive, hematopoi-
esis (Kumano et al., 2003). Notch1 and Notch2 were both upre-
gulated in CD45+ cells, and the former was more highly
expressed in CD45+cKit+ cells and the latter in CD45+cKit cells
(Figures 6D and 6E). Another marker of definitive hematopoiesis
is the Cxcr4 pathway (Moepps et al., 2000).Cxcr4 is expressed in
CD45+ cells along with downstream genes (Figure 6F). HSCs
and immature progenitors silence Moloney-based retrovirus
(Klug et al., 2000). We analyzed pMXs proviral expression by
aligning mRNA-seq reads against the pMXs sequence (Fig-
ure 6G). Retroviral sequences were detected at day 20, consis-
tent with transgene expression (Figure 3B). In CD45+ cells,
pMXs sequences were detected in the CD45+cKit compart-
ment with a 10-fold reduction in CD45+cKit+ cells, consistent
with silencing in HSCs and immature progenitors (Figure 6G).
Collectively, these results highlight the definitive hematopoietic
nature of cells specified by the four TFs.
Specified Cells Contain Cells with an LT-HSC Cell-
Surface Phenotype and Generate Colonies In Vitro after
Reaggregation Culture
We then asked whether global gene expression is reflected in a
LT-HSC cell-surface phenotype. Among Sca1+ cells, 17% were
also CD45+ and GFP+ (Figure 7A, left panels). This compartment
contained cells with a CD48CD150+cKit+ LT-HSC phenotype,
whereas the CD45 compartment did not (Figure 7A, right
panels). To address the clonogenic function of specified he-
matopoietic cells, we transferred Gata2, cFos, Gfi1b, and Etv6
into Dox-inducible lentiviral vectors (Tet-On system, strategy
outlined in Figure S6) to avoid the complications of continued
overexpression or re-expression of TFs. When cultured with
Dox, the transgenes are expressed, and upon Dox withdrawal,
transgene expression is significantly reduced (days 1–3),
becoming undetectable after 6 days (Figure S6A). Expression
of Gata2, cFos, Gfi1b, and Etv6 driven by these vectors in
MEFs from wild-type C57Bl6 mice first induces precursor cells
and, upon continued culture with Dox, the emergence of nonad-
herent CD45+ hematopoietic cells (Figure S6B). Isolation of
emergent CD45+ cells by fluorescence-activated cell sortingell Stem Cell 13, 205–218, August 1, 2013 ª2013 Elsevier Inc. 211
Figure 5. An Endothelial-like Gene-Expression Program Precedes Hematopoietic Specification
MEFs were transduced with four TFs and plated on gelatin without cytokines. Global gene-expression levels in nontransducedMEFs, day 20 GFP+Sca1+Prom1+,
and day 35 GFP+CD45+cKit+ and GFP+CD45+cKit were profiled by mRNA-seq (biological replicates: 1 and 2).
(A) Pictures show morphology of profiled populations. The scale bar represents 100 mm.
(B) Ordered tree linkage displays clustering of the profiled samples and the metagenes that represent most of the variability associated with each cell transition.
(C) PCA shows the relative distances between samples and a hypothetical temporal trajectory.
(D) Reads were aligned to the mouse genome, and those that mapped to the Acta2, Ly6a, Ly6e, and Cd45 genes are displayed as maximum read heights.
(legend continued on next page)
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Induction of Hemogenesis(FACS) and culturing for 10 days without Dox showed that these
cells continue to express CD45 without continued expression
of the exogenous TFs (Figure S6C). To address a possible
requirement for further maturation, we developed a placental
reaggregate culture system similar to one previously reported
for VE-Cadherin+CD45+ cells and AGM (Taoudi et al., 2008).
We reasoned that cellular and/or molecular elements in this tis-
sue could facilitate the maturation of our programmed cells to
a clonogenic ‘‘state.’’ After 25 days of programming culture in
the presence of Dox, induced cells were dissociated and reag-
gregated with irradiated mouse placental cells (E12.5). After 4
or 5 days of culture without Dox, reaggregates were dissociated
and the cells were plated into semisolid media for colony-form-
ing unit (cfu) assays (Figure 7B). We observed the emergence
of hematopoietic (CD45+) colonies under these conditions (Fig-
ures 7C, 7D, and S6D). Four-day reaggregate cultures generated
more cfu than 5 day cultures (Figure 7C). As expected, no col-
onies were observed in aggregates containing only irradiated
placental cells (n = 6). Colonies derived from cfu contain cells
with diversemyeloidmorphologies aswell as blast-like cells (Fig-
ure 7E). As expected, the cells contain transgene integrations
(M2rtTA and Gata2) (Figure 7F). These data further support the
specification of definitive hematopoietic cells by the four tran-
scription factors.
DISCUSSION
We show that the combination of Gata2, Gfi1b, cFos, and Etv6
efficiently activates the 34/H2BGFP reporter and induces he-
matopoietic colonies from MEFs. Although Gata2, Gfi1b, and
cFos are sufficient, Etv6 increases the efficiency up to 6%.
Transduced MEFs first organize into circular endothelial-like
structures that proceed to generate hematopoietic cells with
specifying HSC gene-expression and cell-surface phenotypes.
After placental reaggregation culture, induced cells acquire
in vitro cfu activity. Thus, we provide strong evidence that a com-
plex definitive hemogenic program can be recapitulated in vitro
with a small number of TFs.
Genetic experiments show that the zinc-finger TF Gata2 is
essential for all hematopoietic lineages (Tsai et al., 1994). Mutant
Gata2–/– mice die at E11.5 and show placental neovasculariza-
tion defects caused by reduced secretion of angiogenic prolifer-
ins (Ma et al., 1997; Tsai et al., 1994). Gfi1b is a SNAG (Snail-Gfi)
domain transcriptional repressor. Gfi1b–/– mutants die at E15
from defects in definitive erythroid and megakaryocytic lineages
but have normal vasculature (Lancrin et al., 2012; Saleque et al.,
2002). A recent study identified a positive correlation between
Gata2 and Gfi1b expression at the level of single HSCs(E) The expression levels of fibroblast-specific genes inMEFs (red bars, upper pan
as FPKM mean values ± SEM.
(F) MEFs were transduced with four TFs and analyzed at day 35 by immunofluores
(b) small semiadherent GFP+CD49f+ cells are highlighted. The scale bar represe
(G) Flow plots show the expression of CD49f in the CD45+ and CD45 populatio
(H) Statistically significant genes upregulated from day 0MEFs to day 20 and from
gene-set libraries created from level 4 of the MGI mouse phenotype ontology u
organized on the grid according to gene-list similarity; enriched categories are
values. Relevant terms are highlighted.
(I) Analysis using a gene-set library created from the miRNA prediction tool Target
are highlighted. See also Figures S4 and S5.
C(Moignard et al., 2013). Gata2, Gfi1b, and cFos are essential
for 34/H2BGFP reporter activation and induction of hemogenic
colonies. The cFos TF is a component of the AP-1 complex via
dimerization with cJun proteins. Mice lacking cFos have bone,
hematopoietic, and placental defects (Johnson et al., 1992;
Wang et al., 1992). In endothelial cells, AP-1 cooperates with
Gata2 to induce key endothelial and inflammatory genes (Linne-
mann et al., 2011). Indeed, cFos promotes angiogenesis (Mar-
concini et al., 1999), and Fra-1, a related TF, is required for
placental angiogenesis (Schreiber et al., 2000). A low level of
HSC activity in cFos–/– placentas has been suggested (Otters-
bach and Dzierzak, 2005), and cFos and FosB are specifically
enriched in specifying HSCs (McKinney-Freeman et al., 2012).
In our system, cFos may act by directly promoting endothelial
and hematopoietic gene expression, but the possibility of a
cell-proliferation function analogous to cMyc in iPSC reprogram-
ming cannot be ruled out. The Ets-family TF Etv6 is not essential
but increases reporter-activation efficiency. It is possible that the
increased efficiency is due to enhanced cell survival. Mutant
Etv6–/– mice have defects in yolk-sac angiogenesis and HSC
survival (Hock et al., 2004b; Wang et al., 1997). It is perhaps sur-
prising that exogenous Runx1 is not required for triggering the
hemogenic process; however, Gata2, cFos, and Ets bind to
Runx1 regulatory elements and activate expression (Linnemann
et al., 2011; Nottingham et al., 2007; Wilson et al., 2010). Indeed,
at day 40, endogenous Runx1 was upregulated in GFP+CD45+
cells. Taken together, these data highlight the balance between
endothelial and hematopoietic traits during the generation of he-
matopoietic cells.
Induction of CD45+ hematopoietic cells occurs 30–40 days
after TF transduction. Emergent CD45+cKit+ cells have a gene-
expression profile characteristic of bona fide HSCs. We show
activation of the Notch and Cxcr4 pathways, both with functions
in definitive hematopoiesis. Predicted targets of several miRNAs,
including miR-125, are expressed in CD45+cKit+ cells. We also
demonstrate a subpopulation with a LT-HSC phenotype;
CD150+CD48cKit+ cells are present within emerging CD45+
Sca1+ cells. In addition, 34/H2BGFP expression is highest in
CD45+Sca1+ cells. Emergent CD45+ cells have an overall tran-
scription profile highly similar to nascent or specifying HSCs
from the AGM and placenta and express fetal HSC markers
such as Cd93/AA4.1. These data further highlight the specifica-
tion of hemogenesis by Gata2, cFos, Gfi1b, and Etv6. Culture
conditions have an impact on reprogramming. Differential cyto-
kine (IL-3 and IL-6) and substrate (AFT024 and gelatin) effects at
different stages underscore the stepwise nature of this process.
Reaggregate culture with placental cells at the liquid-gas inter-
face promotes the maturation of specified cells into clonogenicel) and genes overrepresented at day 20 (red bars, lower two panels) are shown
cence for GFP (green) and CD49f staining (red). (a) CD49f+ endothelial-like and
nts 100 mm.
n.
day 20 to day 35 CD45+cKit+ cells were analyzed for gene-list enrichment with
sing Network2Canvas (http://maayanlab.net/N2C/). Phenotype categories are
highlighted by circles. Circle brightness represents increasingly significant p
Scan. MiRNAs implicated in endothelial cells (left panel) or HSPCs (right panel)
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Figure 6. Specified Hematopoietic Cells Display Hallmarks of Definitive Hematopoiesis
(A) GSEA for day 20 and day 35 GFP+CD45+cKit+ samples. Gene-expression lists were analyzed for enrichment of gene sets present in the Molecular Signatures
Database (MSigDB; 1,888 gene sets, gene size 0–5,000). Orange lines represent HSC data sets and gray lines represent non-HSC data sets ordered according to
the normalized enrichment score (NES). The dashed line highlights the cutoff FDR (FDR = 0.25). Right panels show GSEA of NetPath-annotated signaling
pathways. Only enriched pathways are shown (FDR < 0.25, colored according to NES).
(B) GSEA for day 35 CD45+cKit+ and CD45+cKit cells. The dashed line highlights the cutoff (FDR = 0.35). The right panel shows the enrichment plot for one
LT-HSC gene set.
(legend continued on next page)
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Figure 7. Specified Cells Contain a Subpop-
ulation with a LT-HSC Cell-Surface Pheno-
type and Generate In Vitro Colonies after
Reaggregation Culture
(A) A subpopulation of CD150+CD48cKit+ is
present in the Sca1+CD45+ population 30 days
after transduction. The histogram shows reporter
expression in the CD45+ and CD45 compart-
ments of the Sca1+ population. The Sca1+
CD45+CD150+CD48 and Sca1+CD45+CD150+
CD48cKit+ populations represent 1.6% and
0.64% of total cells, respectively.
(B) Reaggregation strategy for cells generatedwith
four inducible TFs (i4TFs) at day 25 (+Dox) and
irradiated mouse placental tissue (E12.5). Reagg-
regateswere cultured (Dox) for 4 or 5 days before
transfer to methylcellulose-containing media.
(C) Clonogenic activity in semisolid media after a
reaggregation step of 4 (d4) or 5 (d5) days. Control
irradiated placenta alone (Plc) did not generate
colonies (n = 6). Colony numbers per three plated
reaggregates (Reag) are shown (mean ± SEM).
Scale bars represent 100 mm.
(D) One colony was manually picked and analyzed
via immunofluorescence for CD45 (red). DAPI
staining is shown in blue. The flow-cytometry plot
shows the percentage of CD45-positive cells (red
line) in three pooled colonies. The control staining
is shown in black. The scale bar represents 20 mm.
(E) Mixed cell morphologies are observed from
cells within the colonies, shown by modified Gi-
emsa staining. The scale bar represents 100 mm.
(F) Integration of inducible lentivirus in five inde-
pendent colonies was confirmed by PCR. The
forward primer is in the lentiviral vector (tetO), and
the reverse is in the coding sequence of Gata2
(lower panel) or M2rtTA (upper panel).
See also Figure S6.
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Induction of Hemogenesisprogenitors, highlighting the role of a permissive environment for
progenitor cell maturation. It will be of critical importance to
develop more-defined culture methods for the controlled matu-
ration of in vitro-programmed aswell as embryo-derived nascent
HSCs into definitive, fully functional HSCs.
We show that hematopoietic cells originate from endothelial-
like precursor cells that express Sca1 (mainly from the Ly6a lo-
cus) and Prom1. Ly6a is expressed before HSC emergence,
and Gata2 haploinsufficient embryos have a 10-fold decrease
in Ly6a-GFP+ aortic endothelial cells (Ling et al., 2004), demon-
strating a link between Gata2 and Ly6a in the AGM. The role of
Prom1 is obscure in the mouse; however, in humans it marks
endothelial progenitor cells (Masuda et al., 2011). Indeed, it
has been shown that a human umbilical cord CD34+Prom1+
population gives rise to both endothelial and hematopoietic cells
(Wu et al., 2007). Prom1 is a target of Gata2 and AP-1 in these(C) Hierarchical clustering showing the integration of gene-expression data from
stages (data from McKinney-Freeman et al., 2012).
(D) The expression of TFs implicated in HSC specification and maintenance is s
resented as mean ± SEM.
(E and F) Heatmap showing the enriched expression of the Notch (E) and Cxcr4 (F)
highlighted in red. FPKM values were analyzed by Cluster and displayed by Tree
expression relative to the mean. Gray designates no detection.
(G)MEFs and day 20 and day 35 CD45+cKit+ and CD45+cKit replicates (1 and 2) w
reads that align to the pMXs long terminal repeats, and the maximum read heigh
Ctwo lineages (Linnemann et al., 2011; Wilson et al., 2010). At
day 20, we detect expression of numerous additional endothelial
genes (Id1, Nos3, KitL, and Cd34) at continually increasing
levels. Other genes implicated in HSC emergence, including
Podxl, Ace, Kdr, Smad6, and Scl, are also expressed at this
time. At day 35, we detect Tie2, VE-Cadherin, and CD31 in asso-
ciation with hematopoietic cell emergence. There is great inter-
est in defining HSC precursors in vivo, and our data may provide
useful markers. Indeed, we demonstrate the expression of po-
tential markers including integrin a-6 (Itga6) (CD49f), shown to
be present on human LT-HSCs (Notta et al., 2011). It will be inter-
esting in future studies to determine whether cells with the
Sca1+Prom1+CD34+CD49f+ precursor phenotype are present
in hemogenic sites during embryonic development. Proliferin
and proliferin-related genes Plf, Plf-2/3, and Plf-4 that have
defined angiogenic functions are also activated (Ma et al.,programmed cells (highlighted in red) with HSCs at several developmental
hown as FPKM values and highlighted in CD45+cKit+ (red bars). Data are rep-
pathway components in CD45+ cells. Notch1, Notch2, and Cxcr4 receptors are
View. Red designates increased expression and green designates decreased
ere analyzed for expression of pMXs vector-derived sequences. Graphs show
ts are displayed.
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Induction of Hemogenesis1997). Low expression of additional hematopoietic genes, for
example Csfr1, is observed at day 20, suggesting that the endo-
thelial-like cells may already be primed for hematopoietic
competence as previously reported in the AGM (Minehata
et al., 2002).
The induction of human progenitor cells has been reported
(Szabo et al., 2010). However, overexpression of Oct4 is likely
to induce plastic intermediates (perhaps on the way to pluripo-
tency) that can be selected for hematopoietic lineages in appro-
priate culture conditions. Extending our directed programming
studies to the human system may shed light on specification of
HSPCs during human embryonic development, as well as robust
in vitro methods to generate such cells.
Collectively, our results show that TFs are sufficient for effi-
cient generation of hematopoietic cells from fibroblasts. This
process is dynamic and proceeds through an endothelial-like in-
termediate. Emergent hematopoietic cells exhibit LT-HSC gene-
expression and cell-surface phenotypes. Our results support the
view that hematopoietic specification is a multistep process and
underscore the requirement for endothelial-like intermediates. In
summary, we demonstrate that a complex and progressive
developmental process can be initiated and sustained in vitro
with a simple combination of TFs and provide insights into the
molecular mechanisms of HSPC specification. These studies
also provide a platform for the future development of patient-
specific HSPCs as well as other blood cells.EXPERIMENTAL PROCEDURES
Mice, MEF Isolation, and Culture
Individual transgenic CD34-tTA (Dan Tenen, Harvard Medical School) and
TetO-H2BGFP (The Jackson Laboratory) mouse lines were established in
the C57BL/6 (CD45.2) background. Double-transgenic (designated 34/
H2BGFP) MEFs were derived from crosses of the two transgenic mice. Cells
from each E14.5 embryo were plated in MEF media, grown for 4–7 days until
confluent, and then split once (Supplemental Experimental Procedures). MEFs
were sorted to remove residual CD45+ and GFP+ cells that could represent
cells with hematopoietic potential and cultured for two additional passages
before plating for retroviral transduction. Animal experiments and procedures
were approved by the Institutional Animal Care and Use Committee and con-
ducted in accordance with the Animal Welfare Act.Viral Transduction and Cell Culture
34/H2BGFP MEFs were seeded at a density of 25,000 cells per well on 0.1%
gelatin-coated 6-well plates and incubated overnight with pools of TF pMXs
retroviruses or pFUW lentiviruses in media supplemented with 8 mg/ml poly-
brene. Equal multiplicities of infection of individual viral particles were applied.
Transductions with mCherry in pMXs or mOrange in pFUW resulted in >95%
efficiency. After 16–20 hr, media was replaced with fresh MEF media supple-
mented with Dox (1 mg/ml) in the case of inducible vectors. At day 4 posttrans-
duction, cells were dissociated with TrypLE Express, and 10,000 cells per well
were plated on 0.1% gelatin-coated 6-well plates containing mitotically inac-
tivated AFT024 stroma. All cultures were maintained in MyeloCult media
(M5300; Stem Cell Technologies) supplemented with hydrocortisone (106
M; Stem Cell Technologies) with or without 100 ng/ml SCF, 100 ng/ml Flt3L,
20 ng/ml IL-3, and 20 ng/ml IL-6 (R&D Systems), with the exception of meth-
ylcellulose cultures, for which cytokine complete MethoCult media was used
(M3434; Stem Cell Technologies) supplemented with 10 ng/ml TPO (R&D Sys-
tems). Media were changed every 6 days for the duration of the cultures.
Emerging GFP+ colonies were counted 21–25 days posttransduction. Experi-
mental details for immunofluorescence, FACS, quantitative RT-PCR (qRT-
PCR), and reaggregation cultures are provided in Supplemental Experimental
Procedures.216 Cell Stem Cell 13, 205–218, August 1, 2013 ª2013 Elsevier Inc.mRNA-Seq Library Preparation, Sequencing, and Analysis
FACS-isolated cells were lysed in Trizol (Ambion). RNA integrity was evaluated
using a eukaryotic RNA 6000 Nano chip on an Agilent 2100 Bioanalyzer (Agi-
lent Technologies). Up to 1 mg of total RNA from each sample was used for li-
brary preparation with the TruSeq RNA Sample Preparation Kit (Illumina). A
common adaptor was used for all samples, and barcode sequences present
in the reverse primer were introduced by 12–16 cycles of amplification (Table
S4). Each library was assessed for quality and size distribution using an Agilent
DNA High Sensitivity Assay Bioanalyzer chip and quantified by real-time PCR.
Equimolar amounts of each barcoded library were mixed and single-end
sequenced on an Illumina HiSeq Sequencing System. For each sample, 14–
21.7 M 50-nt reads were obtained, preprocessed with the FASTX-Toolkit suite
(http://hannonlab.cshl.edu/fastx_toolkit/), and aligned to the mouse genome
(Mus musculus mm9 assembly) using TopHat mapper. Additional analytical
details are provided in Supplemental Experimental Procedures.
ACCESSION NUMBERS
mRNA-seq data were deposited in the Gene Expression Omnibus database
under accession number GSE47497.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
six figures, six tables, and two movies and can be found with this article online
at http://dx.doi.org/10.1016/j.stem.2013.05.024.
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